MD Magazine® Staff

Researchers suggest that acute otitis media rates during a baby’s first year have declined in recent years.

Researchers have called into question patterns of brain activity that have been widely accepted to show pain responses after the team found these patterns in patients who were born without a sense of pain.

The architecture of schizophrenia is in the midst of a renovation, with the details of its clinical course and underlying neurobiology rapidly evolving, with important treatment implications.

The most common and debilitating psychiatric disorder in the world may have a new, innovative treatment thanks to a chemical discovered in the Bruce Hammock laboratory at the University of California, Davis.

Research indicates that serum zinc concentration appears to be inversely associated with serum C-reactive protein concentration, possibly contributing to chronic inflammation, in patients with HIV.

Research indicates that spinal cord stimulation appears to reduce the affective component of pain, resulting in optimal pain relief.

Patients with Parkinson's Disease face a wide range of challenges that can extend to their caregivers. One newly studied area in this field is psychosis for this patient population and what can be done to help them.

In the early stages of treatment for Parkinson's Disease Levodopa is a popular option for patients. As the effects of the medication wear off it can make life difficult for these patients as they wait for their next dose. A new inhaled formulation could help fill in the gaps for this patient population.

Looking to become the latest addition to the field of treatment options for multiple sclerosis Zinbryta continues to show positive results during clinical trials as it awaits the final steps of the regulatory approval process in the United States and elsewhere.

A team of surgeons has demonstrated a surgical model using cadavers for total human eye allotransplantation.

As the population gets older more questions are being asked about what can be done to prevent dementia and whether there are certain activities which are better suited to achieve this goal if it is possible.

Pre-clinical study results appear to demonstrate the efficacy of a new long-acting formulation of the HIV medication raltegravir in preventing vaginal transmission of HIV in animal models.

Researchers report that mindfulness meditation—unlike other cognitive-based approaches to reduce pain, such as hypnosis, acupuncture, distraction, and even the placebo effect—does not appear to utilize the endogenous opioid system to reduce pain.

Patient adherence to oral antibiotic therapy for skin and soft tissue infections after hospital discharge appears to be low and associated with poor clinical outcomes.

New research suggests that sleep problems may be a target for treatment of "emerging adults" with musculoskeletal pain complaints. Sleep issues in this patient group predicted chronic pain and worsening pain severity over time.

Study results confirm that anxiety and depression before surgery can significantly influence the amount of pain a patient feels after surgery, adding to the evidence that the subjective experience of pain is worth considering, both before and after a pain intervention.

A report from the NAS suggests that the elimination of hepatitis B and C as a public health problem is possible, but that time and considerable resources will need to be devoted to stopping the transmission of the disease and treating all those who are infected.

Research indicates that both mindfulness-based stress reduction (MBSR) and cognitive behavioral therapy (CBT) appear to achieve greater improvements in back pain and functional limitations at 26 weeks, when compared with usual care, among adults with chronic low back pain.

The treatment is a fixed-dose combination of emtricitabine 200 mg and tenofovir alafenamide 25 mg.

Persistent parental criticism appears to be among the reasons why attention deficit hyperactivity disorder (ADHD) symptoms persist with age among some children, as opposed to decreasing with age as seen with many children with ADHD.

Potential alternatives to cisplatin have emerged in recent years, including non-platinum-based metal ion complexes. Studies have also shown that nonsteroidal anti-inflammatory drugs (NSAIDs) can fight certain cancers and improve the activity of other agents.

An investigational therapy developed from healthy donor stool specimens treated with ethanol to eliminate pathogens—the resulting spores of which are fractionated and encapsulated for oral delivery as SER-109—appears to effectively treat recurrent Clostridium difficile infection.

A novel clinical intervention that combines mental training through meditation and physical training through aerobic exercise effectively reduces the symptoms of depression.

Research shows that a large majority of patients with chronic pain who are hospitalized after a nonfatal, prescription opioid-related overdose continue to receive this medication, despite discontinuation being associated with lower risk for repeat overdose.

The degree to which the influenza vaccine protects patients from the virus depends on their ethnic background and other inherited factors.

Insomnia and nightmares appear to influence depression symptoms specifically through the pathway of explicit emotion regulation difficulties.

A newly discovered class of anti-biofilm compounds derived from marine microorganisms appears to show promise against a drug-resistant bacterium commonly associated with hospital-acquired infections.

Increasing health care providers' level of awareness and concern regarding prescription drug abuse in their communities may help encourage voluntary reductions in prescribing and/or dispensing of controlled substances

Study results suggest that symptoms consistent with post-traumatic stress disorder, depressive symptoms, physical peer violence, cyberbullying, and community violence exposure appear to be common and interrelated among adolescents presenting to the emergency department.

Researchers in China reported that combination treatment with daclatasvir and asunaprevir produced a sustained virologic response in 91% of patients after 24 weeks of treatment.